Characterization of T cell epitopes of the receptor for hyaluronic acid mediated motility (RHAMM/CD168) in acute myeloid leukemia.

被引：0
|
作者：
Schmitt, M
Li, L
Ringhoffer, M
Barth, T
Wiesneth, M
Dohner, H
Greiner, J
机构：
[1] Univ Ulm, Dept Internal Med 3, D-7900 Ulm, Germany
[2] Univ Ulm, Inst Pathol, D-7900 Ulm, Germany
[3] German Red Cross, Inst Immunogenet & Clin Transfus Med, Ulm, Germany
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2540
引用
收藏
页码：696A / 696A
页数：1
相关论文
共 50 条
  • [31] THE RECEPTOR FOR HYALURONIC ACID MEDIATED MOTILITY (RHAMM): CHARACTERIZATION OF AN IMMUNOTHERAPEUTICAL TARGET WHICH IS ASSOCIATED WITH PROLIFERATION AND SHOWS PROGNOSTIC VALUE IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL) PATIENTS
    Ginnopoulos, K.
    Buehler, A.
    Mertens, D.
    Barth, T.
    Idler, I.
    Kroeber, A.
    Greiner, J.
    Dmoszynska, A.
    Rolinski, J.
    Doehner, H.
    Stilgenbauer, S.
    Schmitt, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 26 - 26
  • [32] Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor Progression
    Schatz-Siemers, Nina
    Chen, Yao-Tseng
    Chen, Zhengming
    Wang, Dunrui
    Ellenson, Lora H.
    Du, Yi-Chieh Nancy
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (06) : 453 - 459
  • [33] Anti-CD123 Chimeric Antigen Receptor Natural Killer cell therapy to treat Acute Myeloid Leukemia.
    Kizerwetter, Monika
    Yang, Huilin
    Rahnama, Ruyan
    Bonifant, Challice
    Spangler, Jamie
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [34] Chimeric Antigen Receptor T Cell Therapy for Acute Myeloid Leukemiachimeric Antigen Receptor T Cell Therapy for Acute Myeloid Leukemia
    Shrestha, Bishwas
    Vishwasrao, Paresh
    Li, Gongbo
    Ghafoor, Tayyebb
    Davila, Marco L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S96 - S97
  • [35] Monitoring of immunoglobulin and T cell receptor genes rearrangements in acute lymphoblastic leukemia.
    Davidjan, Y. R.
    Surin, V. L.
    Parovichnikova, E. N.
    Savchenko, V. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2006, 51 (02): : 3 - 10
  • [36] Alterations of T-cell-mediated immunity in acute myeloid leukemia
    Li, Zhuoyan
    Philip, Mary
    Ferrell, P. Brent
    ONCOGENE, 2020, 39 (18) : 3611 - 3619
  • [37] CD7 and CD56 positive myeloid/natural killer cell precursor acute leukemia.
    Suzuki, R
    Seto, M
    Taji, H
    Yatabe, Y
    Kagami, Y
    Ogura, M
    Ueda, R
    Morishima, Y
    Nakamura, S
    BLOOD, 1997, 90 (10) : 2219 - 2219
  • [38] Alterations of T-cell-mediated immunity in acute myeloid leukemia
    Zhuoyan Li
    Mary Philip
    P. Brent Ferrell
    Oncogene, 2020, 39 : 3611 - 3619
  • [39] Effect of epitopes derived from the mutated region of cytoplasmatic nucleophosmine 1 (NPM1) on CD4+and CD8+T-cell responses in patients with acute myeloid leukemia.
    Greiner, Jochen
    Ono, Yoko
    Hofmann, Susanne
    Schneider, Vanessa
    Schmitt, Anita
    Zhang, Lu
    Mehring, Elmar
    Goetz, Marlies
    Dohner, Konstanze
    Mytilineos, Joannis
    Wiesneth, Markus
    Dohner, Hartmut
    Schmitt, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis
    Kouvidi, Katerina
    Berdiaki, Aikaterini
    Tzardi, Maria
    Karousou, Evgenia
    Passi, Alberto
    Nikitovic, Dragana
    Tzanakakis, George N.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2016, 1860 (04): : 814 - 824
12345